Mucus Hypersecretion Control

Mucus Hypersecretion Control is a therapeutic strategy within mucolytic therapy that specifically targets the reduction of excessive mucus production in respiratory diseases by modulating underlying secretory mechanisms, distinguishing it from interventions focused solely on mucus clearance or viscosity alteration.

149

Publications

5.7K

Citations

900

Authors

302

Institutions

Publications per year

2017–2026

52

Authors

900

  1. FW
    Fuqiang Wen

    Sichuan University, China

    6 publications · 182 citations

    6

    h-index

  2. JM
    Juliy M. Perelman

    Far Eastern Scientific Centre of Physiology and Pathology of Respiration Russian Academy of Medical Sciences, Russia

    6 publications · 232 citations

    6

    h-index

  3. XZ
    Xiangdong Zhou

    Dalian Medical University, China

    5 publications · 172 citations

    5

    h-index

  4. LR
    Lynne Reid

    Royal Brompton Hospital, United Kingdom

    4 publications · 159 citations

    4

    h-index

  5. YM
    Yuichi Majima

    Mie University, Japan

    4 publications · 206 citations

    4

    h-index

1–5 of 900

Venues

  1. PubMed

    Repository · 13 publications · 297 citations

    11

    h-index

  2. Biomedicine & Pharmacotherapy

    6 publications · 178 citations

    6

    h-index

  3. American Journal of Respiratory and Critical Care Medicine

    AJRCCM · 5 publications · 493 citations

    5

    h-index

  4. 4

    h-index

  5. International Immunopharmacology

    4 publications · 133 citations

    4

    h-index

1–5